Henry S. Friedman

467 total citations
9 papers, 319 citations indexed

About

Henry S. Friedman is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henry S. Friedman has authored 9 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Neurology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henry S. Friedman's work include Glioma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (4 papers) and Ocular Oncology and Treatments (2 papers). Henry S. Friedman is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (4 papers) and Ocular Oncology and Treatments (2 papers). Henry S. Friedman collaborates with scholars based in United States and Canada. Henry S. Friedman's co-authors include Michael E. Cohen, Patricia K. Duffner, Peter C. Burger, Marc E. Horowitz, Robert A. Sanford, Larry E. Kun, Jeffrey Krischer, Larry E. Kun, Donald H. Mahoney and J. William Langston and has published in prestigious journals such as Journal of neurosurgery, Neurosurgery and Neuro-Oncology.

In The Last Decade

Henry S. Friedman

9 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry S. Friedman United States 6 274 181 85 80 59 9 319
Masaharu Yasue Japan 8 145 0.5× 127 0.7× 57 0.7× 79 1.0× 71 1.2× 19 279
Alessandro Sandri Italy 11 206 0.8× 117 0.6× 70 0.8× 42 0.5× 89 1.5× 19 329
Anna Maria Cremonini Italy 10 110 0.4× 146 0.8× 52 0.6× 52 0.7× 33 0.6× 13 347
C. Kretschmar United States 8 110 0.4× 207 1.1× 57 0.7× 54 0.7× 111 1.9× 9 328
Yutaka Sawamura Japan 8 371 1.4× 145 0.8× 171 2.0× 113 1.4× 46 0.8× 21 511
X. Murraciole France 5 225 0.8× 57 0.3× 152 1.8× 57 0.7× 112 1.9× 13 323
Brian Rood United States 5 284 1.0× 253 1.4× 73 0.9× 67 0.8× 116 2.0× 6 385
Kimberly R. Porter United States 6 176 0.6× 123 0.7× 97 1.1× 94 1.2× 36 0.6× 8 345
D. Nelson United States 2 470 1.7× 99 0.5× 278 3.3× 208 2.6× 38 0.6× 3 533
Olga Zheludkova Russia 7 201 0.7× 113 0.6× 49 0.6× 36 0.5× 139 2.4× 38 307

Countries citing papers authored by Henry S. Friedman

Since Specialization
Citations

This map shows the geographic impact of Henry S. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry S. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry S. Friedman more than expected).

Fields of papers citing papers by Henry S. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry S. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry S. Friedman. The network helps show where Henry S. Friedman may publish in the future.

Co-authorship network of co-authors of Henry S. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Henry S. Friedman. A scholar is included among the top collaborators of Henry S. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry S. Friedman. Henry S. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mahoney, Donald H., Michael E. Cohen, Henry S. Friedman, et al.. (2000). Carboplatin is effective therapy for young children with progressiveoptic pathway tumors: A Pediatric Oncology Group phase II study. Neuro-Oncology. 2(4). 213–220. 79 indexed citations
2.
Duffner, Patricia K., Jeffrey Krischer, Robert A. Sanford, et al.. (1998). Prognostic Factors in Infants and Very Young Children with Intracranial Ependymomas. Pediatric Neurosurgery. 28(4). 215–222. 106 indexed citations
3.
Duffner, Patricia K., Michael E. Cohen, Robert A. Sanford, et al.. (1995). Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Medical and Pediatric Oncology. 25(1). 38–44. 37 indexed citations
4.
Friedman, Henry S., Edward C. Halperin, Mary Scott Soo, et al.. (1994). Management of pineal non‐germinoma germ cell tumor with residual teratoma and normal alpha‐fetoprotein. Medical and Pediatric Oncology. 22(2). 137–139. 5 indexed citations
5.
Halperin, Edward C., Henry S. Friedman, S. Clifford Schold, et al.. (1993). Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children. Surgical Neurology. 40(4). 278–283. 16 indexed citations
6.
Friedman, Henry S., Marc E. Horowitz, & W. Jerry Oakes. (1991). Tumors of the Central Nervous System: Improvement in Outcome Through a Multimodality Approach. Pediatric Clinics of North America. 38(2). 381–391. 7 indexed citations
7.
Friedman, Henry S., et al.. (1990). Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. Journal of neurosurgery. 72(4). 583–588. 63 indexed citations
8.
Friedman, Henry S. & Jerry Oakes. (1987). Recurrent Brain Tumors in Children. Pediatric Neurosurgery. 13(5). 233–241. 2 indexed citations
9.
Friedman, Henry S., et al.. (1986). Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery. 18(3). 335???40–335???40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaharu Yasue Breakdown of academic impact, for papers by Alessandro Sandri Breakdown of academic impact, for papers by Anna Maria Cremonini Breakdown of academic impact, for papers by C. Kretschmar Breakdown of academic impact, for papers by Yutaka Sawamura Breakdown of academic impact, for papers by X. Murraciole Breakdown of academic impact, for papers by Brian Rood Breakdown of academic impact, for papers by Kimberly R. Porter Breakdown of academic impact, for papers by D. Nelson Breakdown of academic impact, for papers by Olga Zheludkova
Rankless by CCL
2026